Bart Hens is a Principal Scientist in Biopharmaceutics and Biomodeling at Pfizer, focusing on predicting the in vivo performance of drug products for diverse populations. Bart previously served as a Drug Product Design Biomodeler and Biopharmaceutics Scientist at Pfizer from 2020 to 2022, where they conducted biopredictive dissolution tests and in silico modeling. Bart completed a PhD in Pharmaceutical Sciences at KU Leuven and has held various postdoctoral research positions, including at the University of Michigan. Bart is currently an expert panel member at Fonds Wetenschappelijk Onderzoek - Vlaanderen and has gained essential business acumen through training at Vlerick Business School.
This person is not in any teams
This person is not in any offices